Your browser doesn't support javascript.
loading
EWS/FLI mediated reprogramming of 3D chromatin promotes an altered transcriptional state in Ewing sarcoma.
Showpnil, Iftekhar A; Selich-Anderson, Julia; Taslim, Cenny; Boone, Megann A; Crow, Jesse C; Theisen, Emily R; Lessnick, Stephen L.
Afiliação
  • Showpnil IA; Center for Childhood Cancer and Blood Diseases, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH 43205, USA.
  • Selich-Anderson J; Molecular, Cellular, and Developmental Biology Graduate Program, The Ohio State University, Columbus, OH 43210, USA.
  • Taslim C; Center for Childhood Cancer and Blood Diseases, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH 43205, USA.
  • Boone MA; Center for Childhood Cancer and Blood Diseases, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH 43205, USA.
  • Crow JC; Center for Childhood Cancer and Blood Diseases, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH 43205, USA.
  • Theisen ER; Biomedical Sciences Graduate Program, The Ohio State University, Columbus, OH 43210, USA.
  • Lessnick SL; Center for Childhood Cancer and Blood Diseases, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH 43205, USA.
Nucleic Acids Res ; 50(17): 9814-9837, 2022 09 23.
Article em En | MEDLINE | ID: mdl-36124657
ABSTRACT
Ewing sarcoma is a prototypical fusion transcription factor-associated pediatric cancer that expresses EWS/FLI or a highly related FET/ETS chimera. EWS/FLI dysregulates transcription to induce and maintain sarcomagenesis, but the mechanisms utilized are not fully understood. We therefore sought to define the global effects of EWS/FLI on chromatin conformation and transcription in Ewing sarcoma cells using a well-validated 'knock-down/rescue' model of EWS/FLI function in combination with next generation sequencing assays to evaluate how the chromatin landscape changes with loss, and recovery, of EWS/FLI expression. We found that EWS/FLI (and EWS/ERG) genomic localization is largely conserved across multiple patient-derived Ewing sarcoma cell lines. This EWS/FLI binding signature is associated with establishment of topologically-associated domain (TAD) boundaries, compartment activation, enhancer-promoter looping that involve both intra- and inter-TAD interactions, and gene activation. In addition, EWS/FLI co-localizes with the loop-extrusion factor cohesin to promote chromatin loops and TAD boundaries. Importantly, local chromatin features provide the basis for transcriptional heterogeneity in regulation of direct EWS/FLI target genes across different Ewing sarcoma cell lines. These data demonstrate a key role of EWS/FLI in mediating genome-wide changes in chromatin configuration and support the notion that fusion transcription factors serve as master regulators of three-dimensional reprogramming of chromatin.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sarcoma de Ewing / Regulação Neoplásica da Expressão Gênica / Proteínas de Fusão Oncogênica / Proteína EWS de Ligação a RNA / Proteína Proto-Oncogênica c-fli-1 Tipo de estudo: Prognostic_studies Limite: Child / Humans Idioma: En Revista: Nucleic Acids Res Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sarcoma de Ewing / Regulação Neoplásica da Expressão Gênica / Proteínas de Fusão Oncogênica / Proteína EWS de Ligação a RNA / Proteína Proto-Oncogênica c-fli-1 Tipo de estudo: Prognostic_studies Limite: Child / Humans Idioma: En Revista: Nucleic Acids Res Ano de publicação: 2022 Tipo de documento: Article